Benzinga | Nov 17, 2020 08:02AM EST

Ayala Pharmaceuticals Late Monday Reported Q3 EPS $(0.59), Sales $658.00K

Ayala Pharmaceuticals (NASDAQ:AYLA) reported quarterly losses of $(0.59) per share. The company reported $658.00 thousand in sales this quarter.